1. Home
  2. GBIO vs CREX Comparison

GBIO vs CREX Comparison

Compare GBIO & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • CREX
  • Stock Information
  • Founded
  • GBIO 2016
  • CREX N/A
  • Country
  • GBIO United States
  • CREX United States
  • Employees
  • GBIO N/A
  • CREX N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • CREX EDP Services
  • Sector
  • GBIO Health Care
  • CREX Technology
  • Exchange
  • GBIO Nasdaq
  • CREX Nasdaq
  • Market Cap
  • GBIO 29.5M
  • CREX 35.2M
  • IPO Year
  • GBIO 2020
  • CREX N/A
  • Fundamental
  • Price
  • GBIO $4.15
  • CREX $2.64
  • Analyst Decision
  • GBIO Strong Buy
  • CREX Strong Buy
  • Analyst Count
  • GBIO 4
  • CREX 1
  • Target Price
  • GBIO $73.33
  • CREX $6.00
  • AVG Volume (30 Days)
  • GBIO 210.0K
  • CREX 70.5K
  • Earning Date
  • GBIO 08-06-2025
  • CREX 08-13-2025
  • Dividend Yield
  • GBIO N/A
  • CREX N/A
  • EPS Growth
  • GBIO N/A
  • CREX N/A
  • EPS
  • GBIO N/A
  • CREX N/A
  • Revenue
  • GBIO $24,556,000.00
  • CREX $48,303,000.00
  • Revenue This Year
  • GBIO N/A
  • CREX $10.03
  • Revenue Next Year
  • GBIO N/A
  • CREX $18.84
  • P/E Ratio
  • GBIO N/A
  • CREX N/A
  • Revenue Growth
  • GBIO 146.47
  • CREX 1.68
  • 52 Week Low
  • GBIO $3.00
  • CREX $1.28
  • 52 Week High
  • GBIO $34.35
  • CREX $4.85
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 53.64
  • CREX 34.75
  • Support Level
  • GBIO $4.22
  • CREX $2.68
  • Resistance Level
  • GBIO $5.10
  • CREX $3.47
  • Average True Range (ATR)
  • GBIO 0.62
  • CREX 0.21
  • MACD
  • GBIO 0.00
  • CREX -0.05
  • Stochastic Oscillator
  • GBIO 30.14
  • CREX 20.78

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: